Yumab GmbH Alternatives & Competitors

12 companies similar to Yumab GmbH — From Target to Lead

Adimab

Premier Human Antibody Discovery and Engineering Company

137 Venture round

Lebanon, United States

Biotechnology Health Care +1

Bright Peak Therapeutics

Better Biologics Through Chemistry

56 Series C $232.00M

Basel, Switzerland

Biotechnology Health and Wellness +1

Protein Alternatives SL (PROALT)

Proteins and antibodies applied to health

5 Grant $2.31M

Tres Cantos, Spain

Biotechnology Health Care +1

KALSIOM SAS

Targeting calcium signaling to cure auto-immune diseases

Brest, France

Biotechnology Health Care +1

Rival Readout

Competing with Yumab GmbH? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

OncoResponse

Interrogating for Cures

10 $117.10M

Houston, United States

Biopharma Biotechnology +2

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...

San Diego, United States

Biopharma Biotechnology +1

ImmunGene

Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...

Series A $9.00M

Biotechnology Health and Wellness +1

DJS Antibodies

Unlocking immunology to deliver revolutionary medicines

21 Seed

Oxford, United Kingdom

Biotechnology Health Care +1

GigaGen Inc

Overcoming Immune Dysregulation to Fight Disease

54 Acquired $117.54M

San Carlos, United States

Biotechnology Health and Wellness

Merus N.V.

Merus was acquired by Genmab. To see what’s new, visit Genmab.

177 Post-IPO Equity $1.04B

Utrecht, The Netherlands

Biotechnology Health Care +1

X-BODY Biosciences

3 Venture round $6.80M

Biotechnology Health and Wellness +1

About Yumab GmbH

Yumab GmbH is a German biotech company founded in 2012 as a spin-off from the University of Braunschweig. The company has made significant strides in human monoclonal antibody (mAb) development, aligning with the prevailing trend in immunotherapy towards fully human mAbs for therapeutic applications. The YUMAB® antibod...

Business keywords

Biotech Company, Monoclonal Antibodies, Antibody Engineering, Humanization, Antibody Libraries, Antibody Discovery, Therapeutic Antibodies, Contract Research, R&D Services, Immunotherapy, Phage Display, Antibody Optimization, Antibody Affinity Maturation, Antibody Formats

Frequently Asked Questions

Companies similar to Yumab GmbH include Adimab, Bright Peak Therapeutics, Protein Alternatives SL (PROALT), KALSIOM SAS, OncoResponse. They work in Biotechnology and Health and Wellness and share Yumab GmbH's focus on therapeutic antibodies, monoclonal antibodies and antibody discovery.

Bounce Watch lists 12 companies that share Yumab GmbH's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Yumab GmbH: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Yumab GmbH Profile Adimab Alternatives Bright Peak Therapeutics Alternatives Protein Alternatives SL (PROALT) Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Yumab GmbH on 14 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.